Details of the Drug

General Information of Drug (ID: DM21RQ5)

• Drug Name: Progerinin

Indication

Disease Entry	ICD 11	Status	REF
Hutchinson-Gilford progeria syndrome	LD2B	Phase 2	[1]

• Cross-matching ID:
  PubChem CID: 46220467
  TTD ID: DM3F1L

References

• [1] ClinicalTrials.gov (NCT05847179) A Phase 2, Open-Label Study to Evaluate the Safety and Tolerability of Progerinin for the Treatment of Bone Mineral Density (BMD) Loss in Subjects With Typical Werner Syndrome. U.S.National Institutes of Health.